Faeth Therapeutics Statistics
Total Valuation
FTH has a market cap or net worth of $519.39 million. The enterprise value is $333.54 million.
| Market Cap | 519.39M |
| Enterprise Value | 333.54M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FTH has 25.84 million shares outstanding. The number of shares has increased by 88.34% in one year.
| Current Share Class | 25.84M |
| Shares Outstanding | 25.84M |
| Shares Change (YoY) | +88.34% |
| Shares Change (QoQ) | +335.75% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 41.97% |
| Float | 18.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.69, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.69 |
| Quick Ratio | 19.46 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,148.84 |
Financial Efficiency
Return on equity (ROE) is -195.26% and return on invested capital (ROIC) is -22.59%.
| Return on Equity (ROE) | -195.26% |
| Return on Assets (ROA) | -20.79% |
| Return on Invested Capital (ROIC) | -22.59% |
| Return on Capital Employed (ROCE) | -20.46% |
| Weighted Average Cost of Capital (WACC) | 2.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.74M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +79.46% in the last 52 weeks. The beta is -0.29, so FTH's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | +79.46% |
| 50-Day Moving Average | 30.45 |
| 200-Day Moving Average | 24.94 |
| Relative Strength Index (RSI) | 31.97 |
| Average Volume (20 Days) | 335,934 |
Short Selling Information
The latest short interest is 2.07 million, so 8.00% of the outstanding shares have been sold short.
| Short Interest | 2.07M |
| Short Previous Month | 1.32M |
| Short % of Shares Out | 8.00% |
| Short % of Float | 11.17% |
| Short Ratio (days to cover) | 4.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.76M |
| Pretax Income | -195.53M |
| Net Income | -195.53M |
| EBITDA | -36.64M |
| EBIT | -36.76M |
| Earnings Per Share (EPS) | -$82.46 |
Balance Sheet
The company has $186.44 million in cash and $592,000 in debt, with a net cash position of $185.85 million or $7.19 per share.
| Cash & Cash Equivalents | 186.44M |
| Total Debt | 592,000 |
| Net Cash | 185.85M |
| Net Cash Per Share | $7.19 |
| Equity (Book Value) | 172.96M |
| Book Value Per Share | 6.70 |
| Working Capital | 179.08M |
Cash Flow
In the last 12 months, operating cash flow was -$33.86 million and capital expenditures -$6,000, giving a free cash flow of -$33.86 million.
| Operating Cash Flow | -33.86M |
| Capital Expenditures | -6,000 |
| Depreciation & Amortization | 123,000 |
| Net Borrowing | -345,000 |
| Free Cash Flow | -33.86M |
| FCF Per Share | -$1.31 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -88.34% |
| Shareholder Yield | -88.34% |
| Earnings Yield | -410.24% |
| FCF Yield | -6.52% |
Analyst Forecast
The average price target for FTH is $56.14, which is 179.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.14 |
| Price Target Difference | 179.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |